This inventor holds 1 USPTO granted patent. Top assignee: Roche Palo Alto LLC. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Javier De Vincente Fidalgo: Innovator in Antiviral Compounds
Introduction
Javier De Vincente Fidalgo is a notable inventor based in Glen Ridge, NJ (US). He has made significant contributions to the field of antiviral compounds, particularly in the treatment of Hepatitis C virus (HCV) infections. His work has implications for both medical research and pharmaceutical development.
Latest Patents
Javier holds a patent for "Heterocyclic antiviral compounds." This patent includes compounds having the formula I, wherein R, R, R, R, and R are defined as Hepatitis C virus NS5b polymerase inhibitors. The patent also discloses compositions and methods for treating HCV infections and inhibiting HCV replication. He has 1 patent to his name.
Career Highlights
Javier is currently employed at Roche Palo Alto LLC, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in antiviral compounds has positioned him as a valuable asset in the fight against viral infections.
Collaborations
Throughout his career, Javier has collaborated with notable colleagues, including Jim W Li and Ryan Craig Schoenfeld. These partnerships have enhanced his research and contributed to advancements in antiviral therapies.
Conclusion
Javier De Vincente Fidalgo is a distinguished inventor whose work in antiviral compounds is paving the way for new treatments for Hepatitis C. His contributions to the field are invaluable and continue to impact medical research and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile